TIDES Europe 2024 Post-Event Report eBook: Innovations and Efficiencies in Oligonucleotide CMC
In 2024, oligonucleotide chemistry, manufacturing, and controls (CMC) continued to evolve at an unprecedented pace, driven by the growing demand for these versatile therapeutic agents in precision medicine. Innovations in synthesis, analytical characterization, and manufacturing technologies addressed longstanding challenges, such as scalability, quality assurance, and regulatory compliance, while fostering unprecedented efficiencies across the production pipeline.
This year, TIDES Europe featured over 100 speakers of the industry's top scientists who presented the latest science and industry updates across the entire spectrum from discovery, preclinical, and clinical development through CMC, manufacturing, and commercialization of therapeutics and vaccines for oligos, peptides, and mRNA and genome editing products.
Our 2024 content cross-pollinated expertise across the spectrum of Oligonucleotides, Peptides, mRNA, and Genome Editing. The TIDES Europe 2024 program featured concurrent tracks covering 6 scientific themes including in-depth development strategies, trends, and technologies across oligonucleotides, peptides, mRNA, and genome editing spaces.
This eBook highlights key moments of the event and looks at the significance of the research and insights shared in Hamburg this year. Read on to get a sense of what the buzz was like on-site and learn more about the industry-shaping discussions that were shared at TIDES Europe.
We hope to see you next year at TIDES Europe on November 11-13, 2025, at the Congress Center Basel in Basel, Switzerland.
Click below to read the TIDES Europe 2024 Post-Event Report eBook: Innovations and Efficiencies in Oligonucleotide CMC
TIDES Europe 2024 Post-Event Report eBook: Innovations and Efficiencies in Oligonucleotide CMC